← Eichor
Condition: Neuroleptics Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Neuroleptics

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Comparing Antipsychotic Medications in LBD Over Time
Phase 4 · 2 location(s) · The University of Texas Health Science Center at San Antonio · NCT05590637Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Phase 4 · 1 location(s) · Corporal Michael J. Crescenz VA Medical Center · NCT03495024Randomized Withdrawal Study in Patients With Schizophrenia
Phase 3 · 22 location(s) · Vanda Pharmaceuticals · NCT06961968Sex, Psychopharmacology, and Diabetes
NA · 1 location(s) · Zealand University Hospital · NCT05951660Recovery With Exogenous Ketones and Antipsychotics
NA · 1 location(s) · Université de Sherbrooke · NCT07122531Exercise and Olanzapine-samidorphan
Phase 4 · 1 location(s) · New York State Psychiatric Institute · NCT06740890CLOZAPINE Response in Biotype-1
Phase 4 · 5 location(s) · University of Texas Southwestern Medical Center · NCT04580134Cerebellum-based Imaging Neural Markers for Antipsychotic Response
Phase 4 · 1 location(s) · Northwell Health · NCT07483294Multimodal Physical Exercise Program (Physical Exercise for Psychosis) for People With Psychosis Treated With Long-Actin
NA · 1 location(s) · University of Trás-os-Montes and Alto Douro · NCT07360665Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities
Phase 4 · 1 location(s) · University Hospitals Cleveland Medical Center · NCT06997198Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability
Phase 4 · 1 location(s) · Centre for Addiction and Mental Health · NCT05744479Effect of Amitriptyline and Trifluoperazine on Patients With Functional Dyspepsia
Phase 2/Phase 3 · 1 location(s) · Md. Moktadirul Hoque Shuvo · NCT07008235Maternal And Infant Antipsychotic Study
Phase N/A · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06049953iTBS for Increased Appetite Induced by Antipsychotics
NA · 2 location(s) · Central South University · NCT05783063Deprescribing Antipsychotics: a Multiple Case Study
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07343193Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant
Phase 3 · 10 location(s) · Newron Pharmaceuticals SPA · NCT07184619Effects of Cognitive Behavioral Therapy Through a Mobile App on Patients With Refractory Functional Dyspepsia
NA · 7 location(s) · Air Force Military Medical University, China · NCT06756139AP Metabolism Transcriptomics
Phase N/A · 1 location(s) · IRCCS Eugenio Medea · NCT06814314Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic
NA · 1 location(s) · Bjorn H. Ebdrup · NCT06624462Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)
NA · 1 location(s) · Guangdong Provincial People's Hospital · NCT07025590Effects of Antipsychotics on Brain Insulin Action in Females
NA · 1 location(s) · Centre for Addiction and Mental Health · NCT06251635A Probiotic Strategy for Antipsychotic-induced Metabolic Dysfunction
NA · 2 location(s) · University College Cork · NCT06729671Immune Mechanisms of Antipsychotic Treatment Response
Phase N/A · 1 location(s) · King's College London · NCT06687694Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polyphar
NA · 3 location(s) · Ludwig-Maximilians - University of Munich · NCT05842928"Extended" (Alternate Day) Antipsychotic Dosing
Phase 4 · 1 location(s) · Centre for Addiction and Mental Health · NCT04478838Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients
Phase 3 · 1 location(s) · Tanta University · NCT05669742Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia
NA · 1 location(s) · Centre for Addiction and Mental Health · NCT05748990No Guts No Glory Probiotics
Phase 2/Phase 3 · 3 location(s) · University Medical Center Groningen · NCT07606014The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receivi
NA · 1 location(s) · DINA KEUMALA SARI · NCT07696000Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
Phase 2 · 2 location(s) · New York State Psychiatric Institute · NCT05999240
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.